These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7477597)

  • 1. [Therapeutic use of neuroleptics. Satellite symposium "Risperdal: new horizons for the schizophrenic patient". 9th World Congress for Psychiatry, Rio de Janeiro, 6-12 June 1993].
    Nervenarzt; 1993 Nov; 64(11 Suppl):1-8. PubMed ID: 7477597
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone: new horizons for the schizophrenic patient. 9th World Congress of Psychiatry of the World Psychiatric Association, Rio de Janeiro, June 1993.
    Kane JM
    J Clin Psychiatry; 1994 May; 55 Suppl():3-4. PubMed ID: 7520907
    [No Abstract]   [Full Text] [Related]  

  • 3. Combining risperidone with standard neuroleptics for refractory schizophrenic patients.
    Bacher NM; Kaup BA
    Am J Psychiatry; 1996 Jan; 153(1):137. PubMed ID: 8540580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharma-clinics. Drug of the month. Risperidone (Risperdal)].
    Ansseau M
    Rev Med Liege; 1996 Oct; 51(10):665-7. PubMed ID: 8984564
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risperidon: an advance for schizophrenic patients. Why new neuroleptics?].
    Nervenarzt; 1994 May; 65(5 Suppl [risperid]):1-4. PubMed ID: 9131087
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuro-cognition and schizophrenia. 11th World Congress for Psychiatry. Hamburg, 8 August 1999].
    Psychiatr Prax; 1999 Nov; 26(6 Suppl):1-4. PubMed ID: 10643592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].
    Briken P; Nika E; Krausz M; Naber D
    Fortschr Neurol Psychiatr; 2002 Mar; 70(3):139-44. PubMed ID: 11880946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone failed to improve polydipsia-hyponatremia of the schizophrenic patients.
    Kawai N; Baba A; Suzuki T
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):107-10. PubMed ID: 11929579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viewpoint of schizophrenic patients: a European survey].
    Courtet P
    Encephale; 2001; 27(1):28-38. PubMed ID: 11294036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
    Heresco-Levy U; Ermilov M; Shimoni J; Shapira B; Silipo G; Javitt DC
    Am J Psychiatry; 2002 Mar; 159(3):480-2. PubMed ID: 11870017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paliperidone, risperidone].
    Takeuchi K; Sanjo K; Sakai A
    Nihon Rinsho; 2013 Apr; 71(4):654-9. PubMed ID: 23678595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone and cognitive functioning in elderly schizophrenic patients.
    Reznik I; Paleacu D
    Am J Geriatr Psychiatry; 2000; 8(2):177. PubMed ID: 10804081
    [No Abstract]   [Full Text] [Related]  

  • 13. [3 years of risperidone: from innovation to example].
    Nervenarzt; 1997 Apr; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
    [No Abstract]   [Full Text] [Related]  

  • 14. Schizophrenia treatment: the use of atypical drugs--risperdal, zyperexa, and clozaril.
    Kalinyak CM
    Int J Psychiatr Nurs Res; 1998 Sep; 4(2):445-51. PubMed ID: 10451301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent developments in antipsychotic medication].
    Möller HJ
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):230-9. PubMed ID: 8658104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol.
    Liu SK; Chen WJ; Chang CJ; Lin HN
    Neuropsychopharmacology; 2000 Mar; 22(3):311-9. PubMed ID: 10693159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study: risperidone in children and adolescents with schizophrenia.
    Quintana H; Keshavan M
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1292-6. PubMed ID: 7592266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract]   [Full Text] [Related]  

  • 19. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents.
    Ren XS; Qian S; Lee AF; Herz L; Miller DR; Kazis LE
    J Clin Pharm Ther; 2006 Feb; 31(1):57-65. PubMed ID: 16476121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.